iShares US Pharmaceuticals ETF (IHE) To Go Ex-Dividend on June 17th

Share on StockTwits

iShares US Pharmaceuticals ETF (NYSEARCA:IHE) declared a quarterly dividend on Monday, June 17th, Wall Street Journal reports. Stockholders of record on Tuesday, June 18th will be given a dividend of 0.5352 per share on Friday, June 21st. This represents a $2.14 annualized dividend and a dividend yield of 1.46%. The ex-dividend date of this dividend is Monday, June 17th.

IHE stock opened at $146.86 on Wednesday. iShares US Pharmaceuticals ETF has a 52-week low of $131.91 and a 52-week high of $170.26.

TRADEMARK VIOLATION WARNING: “iShares US Pharmaceuticals ETF (IHE) To Go Ex-Dividend on June 17th” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/4378677/ishares-us-pharmaceuticals-etf-ihe-to-go-ex-dividend-on-june-17th.html.

iShares US Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.

Recommended Story: What is the market perform rating?

Dividend History for iShares US Pharmaceuticals ETF (NYSEARCA:IHE)

Receive News & Ratings for iShares US Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares US Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

William I. Jacobs Sells 600 Shares of Global Payments Inc  Stock
William I. Jacobs Sells 600 Shares of Global Payments Inc Stock
Stewart Butterfield Sells 2,500 Shares of Slack  Stock
Stewart Butterfield Sells 2,500 Shares of Slack Stock
Alice Lindsay Caulder Sells 501 Shares of World Acceptance Corp.  Stock
Alice Lindsay Caulder Sells 501 Shares of World Acceptance Corp. Stock
Insider Buying: ALS Ltd  Insider Buys 14,983 Shares of Stock
Insider Buying: ALS Ltd Insider Buys 14,983 Shares of Stock
Opko Health Inc.  CEO Purchases $106,000.00 in Stock
Opko Health Inc. CEO Purchases $106,000.00 in Stock
Robert Langer Sells 7,500 Shares of Rubius Therapeutics Inc  Stock
Robert Langer Sells 7,500 Shares of Rubius Therapeutics Inc Stock


© 2006-2019 Ticker Report